Loading...
XNAS
NAKA
Market cap22mUSD
Jul 09, Last price  
3.81USD
1D
1.60%
1Q
-56.47%
IPO
-96.42%
Name

Kindly MD Inc

Chart & Performance

D1W1MN
XNAS:NAKA chart
P/E
P/S
12.60
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
2m
-33.04%
2,504,3193,787,0773,768,5982,719,8401,821,315
Net income
-52m
L+1,343.73%
149,336-2,540,593-1,617,461-3,617,647-52,228,923
CFO
-24m
L+664.88%
121,441-140,383-449,489-3,073,891-23,511,499

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kindly MD, Inc. functions as a company specializing in both healthcare provision and health data management. It delivers direct patient care by integrating prescription medication management with behavioral health services. The firm offers specialized outpatient clinical services, accessible through both subscription-based plans and a fee-for-service structure, designed to complement conventional medical provisions. Its comprehensive service portfolio includes evaluation and management for various conditions such as chronic pain, functional medicine requirements, cognitive behavioral therapy (CBT), trauma and addiction recovery support, overdose prevention education, and peer-assisted programs. The company also provides limited urgent care, preventative medicine, travel-related health consultations, and hormone therapy. Beyond clinical services, Kindly MD, Inc. engages in data collection and research, executes online and email marketing campaigns, and retails healthcare products both within its clinics and through digital channels. Established in 2019 and headquartered in Salt Lake City, Utah, the company was formerly known as Utah Therapeutic Health Center, LLC before rebranding to Kindly MD, Inc. in March 2022.
IPO date
May 31, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT